Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3
The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Lactic Acid SCHEMBL446198 | 1.00 | TP53 (0.44) | TP53CA1CA2CA4CYP3A4 | |
| L-Lactic Acid SCHEMBL446197 | 1.00 | TP53 (0.44) | TP53CA1CA2CA4CYP3A4 | |
| L-Lactic Acid SCHEMBL9250496 | 0.97 | — | — | |
| L-Lactic Acid SCHEMBL3458055 | 0.97 | — | — | |
| L-Lactic Acid SCHEMBL4510537 | 0.97 | TP53 (0.47) | TP53CA1CA2CA4CYP3A4 | |
| L-Lactic Acid SCHEMBL10791430 | 0.97 | TP53 (0.47) | TP53CA1CA2CA4CYP3A4 | |
| L-Lactic Acid SCHEMBL5182015 | 0.93 | CA4 (0.44) | TP53CA1CA2CA4CYP3A4 | |
| L-Lactic Acid SCHEMBL31753630 | 0.93 | — | — | |
| L-Lactic Acid SCHEMBL11097690 | 0.93 | TP53 (0.44) | TP53CA1CA2CA4CYP3A4 | |
| L-Lactic Acid SCHEMBL7999572 | 0.93 | TP53 (0.50) | TP53CA1CA2CA4CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101426489-A | Compositions and methods for inhibiting angiogenesis | YIHALI CAO (SE) | 2009-05-06 | — | — | CN | disclosed |
| US-5696237-A | Recombinant antibody-toxin fusion protein | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-12-09 | — | — | US | disclosed |